SeaStar Medical Holding Co. (NASDAQ:ICU) Sees Significant Decline in Short Interest

SeaStar Medical Holding Co. (NASDAQ:ICU) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 3,280,000 shares, a decline of 8.6% from the March 31st total of 3,590,000 shares. Approximately 6.4% of the company’s stock are sold short. Based on an average trading volume of 5,780,000 shares, the short-interest ratio is presently 0.6 days.

SeaStar Medical Trading Up 16.8 %

ICU stock traded up $0.07 during trading on Monday, reaching $0.51. 2,305,896 shares of the stock were exchanged, compared to its average volume of 5,268,230. SeaStar Medical has a twelve month low of $0.16 and a twelve month high of $2.27. The firm’s 50 day moving average is $0.76 and its 200 day moving average is $0.68. The firm has a market cap of $38.78 million, a P/E ratio of -0.42 and a beta of -1.18.

SeaStar Medical (NASDAQ:ICU) last issued its quarterly earnings data on Tuesday, April 16th. The company reported ($0.19) earnings per share (EPS) for the quarter.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.